Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease: Patient Registry

NCT05536310 is registered in ClinicalTrials.gov with JenaValve Technology, Inc. as lead sponsor.

NCT NCT05536310
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05536310 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease: Patient Registry
Lead sponsor
JenaValve Technology, Inc.
Phase
Observational
Overall status
Terminated
Start date
August 1, 2023
Completion date
July 9, 2024
Enrollment
24 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis, severe, aortic valve disease, aortic valve regurgitation, aortic valve stenosis, aortic valve stenosis with insufficiency, cardiovascular diseases in old age, constriction, pathologic, heart valve diseases, ventricular outflow obstruction